📰 Bod Science News
Bod Science News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bod Science. Real-time updates on events, politics, business and more.
November 2, 2023
The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).
November 2, 2023
The pharmaceutical and nutritional products specialist dsm-firmenich aims to make better formulations of cannabidiol (CBD).
October 7, 2023
Whilst it may not be a huge deal, we thought it was good to see that the Bod Science Limited ( ASX:BOD ) Non-Executive...
September 7, 2023
Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine.
August 31, 2023
Bod Science ( ASX:BOD ) Full Year 2023 Results Key Financial Results Revenue: AU$3.64m (down 28% from FY 2022). Net...
July 11, 2023
Australia's Bod Science Limited (ASX:BOD) has completed its phase IIB clinical trial for a potential Schedule 3 cannabidiol (CBD) product.
March 3, 2023
Three clinical trials, three failures to beat placebo, yet cannabidiol (CBD) champions believe they can still make low dose meds work for insomnia.